JPMorgan Chase & Co’s Vicarious Surgical RBOT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $661 | Buy |
88
+7
| +9% | +$53 | ﹤0.01% | 5778 |
|
2025
Q1 | $531 | Sell |
81
-3,450
| -98% | -$22.6K | ﹤0.01% | 5821 |
|
2024
Q4 | $46.5K | Buy |
3,531
+2,044
| +137% | +$26.9K | ﹤0.01% | 5037 |
|
2024
Q3 | $8.45K | Buy |
1,487
+1,406
| +1,736% | +$7.99K | ﹤0.01% | 5348 |
|
2024
Q2 | $475 | Sell |
81
-4,054
| -98% | -$23.8K | ﹤0.01% | 5668 |
|
2024
Q1 | $37.4K | Buy |
4,135
+1,304
| +46% | +$11.8K | ﹤0.01% | 5065 |
|
2023
Q4 | $31.1K | Buy |
2,831
+1,313
| +86% | +$14.4K | ﹤0.01% | 5145 |
|
2023
Q3 | $26.9K | Sell |
1,518
-347
| -19% | -$6.15K | ﹤0.01% | 5074 |
|
2023
Q2 | $102K | Buy |
1,865
+450
| +32% | +$24.7K | ﹤0.01% | 4620 |
|
2023
Q1 | $96K | Buy |
1,415
+382
| +37% | +$25.9K | ﹤0.01% | 4667 |
|
2022
Q4 | $62K | Buy |
1,033
+39
| +4% | +$2.34K | ﹤0.01% | 4662 |
|
2022
Q3 | $100K | Buy |
994
+22
| +2% | +$2.21K | ﹤0.01% | 4470 |
|
2022
Q2 | $86K | Buy |
972
+281
| +41% | +$24.9K | ﹤0.01% | 4695 |
|
2022
Q1 | $105K | Sell |
691
-264
| -28% | -$40.1K | ﹤0.01% | 4721 |
|
2021
Q4 | $304K | Buy |
+955
| New | +$304K | ﹤0.01% | 4330 |
|